ES2601028T3 - Método de medición inmunológica para el precursor del péptido liberador de gastrina - Google Patents

Método de medición inmunológica para el precursor del péptido liberador de gastrina Download PDF

Info

Publication number
ES2601028T3
ES2601028T3 ES07850416.4T ES07850416T ES2601028T3 ES 2601028 T3 ES2601028 T3 ES 2601028T3 ES 07850416 T ES07850416 T ES 07850416T ES 2601028 T3 ES2601028 T3 ES 2601028T3
Authority
ES
Spain
Prior art keywords
measurement method
releasing peptide
peptide precursor
immunological measurement
gastrin releasing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07850416.4T
Other languages
English (en)
Inventor
Toru Yoshimura
Kenju Fujita
Barry L. Dowell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2601028T3 publication Critical patent/ES2601028T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5758—Gastrin releasing peptide

Abstract

Un método para analizar ProGRP en una muestra de suero, comprendiendo el método: añadir a una muestra de suero que contiene ProGRP obtenido de un sujeto un inhibidor o un inactivador de un activador de un factor de coagulación de la sangre o un factor fibrinolítico; y analizar la muestra de suero para determinar región 31-98 de ProGRP.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7

Claims (1)

  1. imagen1
ES07850416.4T 2006-12-11 2007-12-11 Método de medición inmunológica para el precursor del péptido liberador de gastrina Active ES2601028T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006333072A JP5201822B2 (ja) 2006-12-11 2006-12-11 ガストリン放出ペプチド前駆体の免疫学的測定方法
JP2006333072 2006-12-11
PCT/JP2007/073854 WO2008072621A1 (ja) 2006-12-11 2007-12-11 ガストリン放出ペプチド前駆体の免疫学的測定方法

Publications (1)

Publication Number Publication Date
ES2601028T3 true ES2601028T3 (es) 2017-02-14

Family

ID=39511642

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07850416.4T Active ES2601028T3 (es) 2006-12-11 2007-12-11 Método de medición inmunológica para el precursor del péptido liberador de gastrina

Country Status (6)

Country Link
US (3) US20100136711A1 (es)
EP (1) EP2103938B1 (es)
JP (1) JP5201822B2 (es)
ES (1) ES2601028T3 (es)
MX (2) MX340107B (es)
WO (1) WO2008072621A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5201822B2 (ja) 2006-12-11 2013-06-05 アボット・ラボラトリーズ ガストリン放出ペプチド前駆体の免疫学的測定方法
FI20115367A0 (fi) * 2011-04-15 2011-04-15 Hytest Oy Menetelmä sydän- ja verisuonitapahtumien määrittämiseksi käyttämällä IGFBP-fragmentteja
CN108333360A (zh) * 2017-01-19 2018-07-27 深圳市新产业生物医学工程股份有限公司 胃泌素释放肽前体稀释液及其应用和试剂盒
CN108107224A (zh) * 2017-12-18 2018-06-01 郑州安图生物工程股份有限公司 一种ProGRP含量测定用液态校准品
CN108279307B (zh) * 2018-01-30 2021-01-26 郑州安图生物工程股份有限公司 保护和稳定血清或血浆中胃泌素释放肽前体的采血管
CN108982858B (zh) * 2018-07-05 2021-06-15 陕西师范大学 一种基于单克隆抗体检测人proGRP的双夹心ELISA试剂盒
CN109342728A (zh) * 2018-10-18 2019-02-15 郑州标源生物科技有限公司 一种适用肿瘤标志物Pro-GRP定量检测的质控品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256540A (en) * 1990-12-28 1993-10-26 Mayo Foundation For Medical Education And Research Immunoassay for small cell lung carcinoma
CA2089212C (en) * 1992-06-12 2004-01-20 Ken Yamaguchi Antibodies to human gastrin-releasing peptide precusor and use thereof
JP3210994B2 (ja) * 1992-06-12 2001-09-25 株式会社先端生命科学研究所 ヒトガストリン放出ペプチド前駆体に対する抗体及びその使用
JP2003270238A (ja) * 2002-03-14 2003-09-25 Sanyo Chem Ind Ltd 体液検査用具
KR101282811B1 (ko) * 2005-04-13 2013-07-05 가부시끼가이샤 센탈 세메 가가꾸 겐꾸쇼 가스트린 방출 펩티드 전구체에 대한 항체 및 그 용도
US20080160545A1 (en) * 2006-09-05 2008-07-03 Abbott Laboratories Pro-GRP as a surrogate marker to predict and monitor response to Bcl-2 inhibitor therapy
WO2008029965A1 (en) * 2006-09-08 2008-03-13 Peoplebio, Inc. Simultaneous reaction assay for differentially detecting multimeric form
JP5201822B2 (ja) 2006-12-11 2013-06-05 アボット・ラボラトリーズ ガストリン放出ペプチド前駆体の免疫学的測定方法

Also Published As

Publication number Publication date
JP2008145278A (ja) 2008-06-26
US10067124B2 (en) 2018-09-04
US9459248B2 (en) 2016-10-04
US20100136711A1 (en) 2010-06-03
EP2103938A4 (en) 2010-06-30
JP5201822B2 (ja) 2013-06-05
WO2008072621A1 (ja) 2008-06-19
US20170089889A1 (en) 2017-03-30
US20140287532A1 (en) 2014-09-25
EP2103938B1 (en) 2016-08-31
MX2009006168A (es) 2009-06-19
EP2103938A1 (en) 2009-09-23
MX340107B (es) 2016-06-27

Similar Documents

Publication Publication Date Title
ES2601028T3 (es) Método de medición inmunológica para el precursor del péptido liberador de gastrina
ES2484142T3 (es) Diagnóstico molecular y clasificación del melanoma maligno
ES2554993T3 (es) Sistema de análisis para el análisis de muestras biológicas, métodos y producto de programa informático
Seebacher et al. The value of serum albumin as a novel independent marker for prognosis in patients with endometrial cancer
ES2527776T3 (es) Biomarcadores para predecir la sensibilidad de células a compuestos inmunomoduladores durante el tratamiento del linfoma no Hodgkin
ES2494915T3 (es) P53 natural como biomarcador para el tratamiento con inhibidores de mTOR en combinación con un agente citotóxico
CR20110567A (es) Dispositivos para diagnostico y metodos relacionados
AR057153A1 (es) Metodo in vitro no invasivo para detectar carcinoma transicional de vejiga
DOP2006000182A (es) Medidor con alarma de tiempo postprandial para efectuar determinaciones
DK1540010T3 (da) Anvendelse af biomarkører til påvisning af ovariecancer
RU2009139295A (ru) Биомаркеры и биомаркерные признаки почечной сохранности, обладающие предсказательной силой, для использования в мониторинге состояния почек
ES2581774T3 (es) Marcadores y métodos de evaluación y tratamiento de colitis ulcerosa y trastornos relacionados mediante un panel de 20 genes
WO2008070865A3 (en) Materials and methods for efficient and accurate detection of analytes
EP1845363A3 (en) Sample analyzer
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
ES2550766T3 (es) Método para la determinación simultánea de varias proteasas de coagulación
PE20141450A1 (es) Ensayo de lisiloxidasa-homologo 2 y metodos de uso del mismo
BRPI0412549A (pt) dispositivo e método de amostragem para um analisador automático
Dam et al. Prospective study of chromogranin A as a predictor of progression in patients with pancreatic, small-intestinal, and unknown primary neuroendocrine tumors
UY30893A1 (es) Metodos y dispositivos para el diagnostico de apendicitis
DE602006021777D1 (de) Diagnoseverfahren für präeklampsie
DE60129151D1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
CL2011002509A1 (es) Cartucho para la verificacion y el analisis cuantitativo de analito en un liquido de muestra que incorpora una camara de reactivos, una camara de deteccion; procedimiento para analisis cuantitativo de analito; y uso del cartucho.
DE602006021038D1 (de) Verfahren zur diagnose eines ovarialkarzinoms
BRPI0812875B8 (pt) " método in vitro para indentificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, e, kit de teste